CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Del Laboratories LLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Del Laboratories LLC
726 RECKSON PLAZA,
P.O. Box 9357
Phone: (516) 844-2020p:516 844-2020 UNIONDALE, NY  11553-9357  United States

This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Del Laboratories, LLC, formerly Del Laboratories, Inc., manufactures, markets and distributes cosmetics and proprietary over-the-counter pharmaceuticals. The cosmetics business is conducted primarily by the Company and its wholly owned subsidiary, Del Laboratories (Canada) Inc., which sells Del Laboratories' cosmetics products to the Canadian market. The pharmaceuticals business is conducted primarily by the Company's wholly owned subsidiary, Del Pharmaceuticals, Inc., and its wholly owned subsidiary, Del Pharmaceutics (Canada) Inc., which sells the Company's pharmaceutical products to the Canadian market. In January 2007, Del Laboratories, Inc. was acquired by Coty Inc.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/200412/31/2003YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Financial Officer JosephSinicropi
Executive VP, Operations Cary C.Newman 62
Vice President, Scientific Affairs Bruce J.MacKay
3 additional Officers and Directors records available in full report.

Business Names
Business Name
565 Broad Hollow Realty Corp.
Del Laboratories (Canada) Inc.
Del Laboratories U.K. Limited
4 additional Business Names available in full report.

General Information
Stock Exchange: AMEX
Federal Tax Id: 131953103


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023